Skip to main content
Top
Published in: Sleep and Breathing 2/2016

01-05-2016 | Sleep Breathing Physiology and Disorders • Original Article

Elevated low-density lipoprotein cholesterol is independently associated with obstructive sleep apnea: evidence from a large-scale cross-sectional study

Authors: Huajun Xu, Jian Guan, Hongliang Yi, Jianyin Zou, Lili Meng, Xulan Tang, Huaming Zhu, Dongzhen Yu, Huiqun Zhou, Kaiming Su, Yue Wang, Jian Wang, Shankai Yin, The Shanghai Sleep Health Study Research Group

Published in: Sleep and Breathing | Issue 2/2016

Login to get access

Abstract

Background

Lipid metabolism disorder is recognized to be associated with obstructive sleep apnea (OSA); however, inconsistent results have been reported. The aim of this study was to evaluate the association between lipid profile and OSA with adjustments for multiple confounding factors.

Methods

In total, 2983 subjects were recruited from the Shanghai Sleep Health Study (SSHS) during 2007–2013. Data for overnight polysomnography (PSG) parameters, serum lipids, fasting blood glucose, insulin levels, and anthropometric measurements were collected. Multivariable logistic regression analyses were used to determine the correlation between lipid profile and OSA with adjustments for confounders including lipids, age, gender, Epworth sleepiness scale, body mass index, waist/hip ratio, glucose, insulin resistance, hypertension, and smoking.

Results

The prevalence of hyper total cholesterol (TC), hyper triglycerides, hypo high-density lipoprotein cholesterol, hyper low-density lipoprotein cholesterol (LDL-C), hyper apolipoprotein (apo) A-I, and hyper apoB differed significantly between the non-OSA and OSA patients. Without considering the interaction across different lipids, TC, LDL-C, and apoB were independently associated with OSA in primary multivariable logistic regression analyses; the odds ratios (ORs) and 95 % confidence intervals (CIs) were 1.262 (1.109–1.438), 1.432 (1.233–1.664), and 5.582 (2.643–11.787), respectively. However, only LDL-C (OR = 1.430, 95 % CI = 1.221–1.675) was found to be an independent risk factor for OSA in further multivariable logistic regression analyses.

Conclusions

We demonstrated that patients with OSA had a higher percentage of dyslipidemia than subjects without OSA. Of the various components in serum lipid, only LDL-C was independently associated with OSA.
Literature
1.
go back to reference Young T, Palta M, Dempsey J, Skatrud J, Weber S et al (1993) The occurrence of sleep-disordered breathing among middle-aged adults. N Engl J Med 328:1230–1235CrossRefPubMed Young T, Palta M, Dempsey J, Skatrud J, Weber S et al (1993) The occurrence of sleep-disordered breathing among middle-aged adults. N Engl J Med 328:1230–1235CrossRefPubMed
2.
go back to reference Peppard PE, Young T, Barnet JH, Palta M, Hagen EW et al (2013) Increased prevalence of sleep-disordered breathing in adults. Am J Epidemiol 177:1006–1014CrossRefPubMedPubMedCentral Peppard PE, Young T, Barnet JH, Palta M, Hagen EW et al (2013) Increased prevalence of sleep-disordered breathing in adults. Am J Epidemiol 177:1006–1014CrossRefPubMedPubMedCentral
3.
go back to reference Bradley TD, Floras JS (2009) Obstructive sleep apnoea and its cardiovascular consequences. Lancet 373:82–93CrossRefPubMed Bradley TD, Floras JS (2009) Obstructive sleep apnoea and its cardiovascular consequences. Lancet 373:82–93CrossRefPubMed
4.
go back to reference Lavie L, Lavie P (2009) Molecular mechanisms of cardiovascular disease in OSAHS: the oxidative stress link. Eur Respir J 33:1467–1484CrossRefPubMed Lavie L, Lavie P (2009) Molecular mechanisms of cardiovascular disease in OSAHS: the oxidative stress link. Eur Respir J 33:1467–1484CrossRefPubMed
5.
go back to reference Baguet JP, Barone-Rochette G, Tamisier R, Levy P, Pepin JL (2012) Mechanisms of cardiac dysfunction in obstructive sleep apnea. Nat Rev Cardiol 9:679–688CrossRefPubMed Baguet JP, Barone-Rochette G, Tamisier R, Levy P, Pepin JL (2012) Mechanisms of cardiac dysfunction in obstructive sleep apnea. Nat Rev Cardiol 9:679–688CrossRefPubMed
7.
go back to reference Ridker PM (2014) LDL cholesterol: controversies and future therapeutic directions. Lancet 384:607–617CrossRefPubMed Ridker PM (2014) LDL cholesterol: controversies and future therapeutic directions. Lancet 384:607–617CrossRefPubMed
8.
9.
go back to reference Toyama Y, Chin K, Chihara Y, Takegami M, Takahashi K et al (2013) Association between sleep apnea, sleep duration, and serum lipid profile in an urban, male, working population in Japan. Chest 143:720–728CrossRefPubMed Toyama Y, Chin K, Chihara Y, Takegami M, Takahashi K et al (2013) Association between sleep apnea, sleep duration, and serum lipid profile in an urban, male, working population in Japan. Chest 143:720–728CrossRefPubMed
10.
go back to reference Trzepizur W, Le Vaillant M, Meslier N, Pigeanne T, Masson P et al (2013) Independent association between nocturnal intermittent hypoxemia and metabolic dyslipidemia. Chest 143:1584–1589CrossRefPubMed Trzepizur W, Le Vaillant M, Meslier N, Pigeanne T, Masson P et al (2013) Independent association between nocturnal intermittent hypoxemia and metabolic dyslipidemia. Chest 143:1584–1589CrossRefPubMed
11.
go back to reference Togeiro SM, Carneiro G, Ribeiro Filho FF, Zanella MT, Santos-Silva R et al (2013) Consequences of obstructive sleep apnea on metabolic profile: a population-based survey. Obesity (Silver Spring) 21:847–851CrossRef Togeiro SM, Carneiro G, Ribeiro Filho FF, Zanella MT, Santos-Silva R et al (2013) Consequences of obstructive sleep apnea on metabolic profile: a population-based survey. Obesity (Silver Spring) 21:847–851CrossRef
12.
go back to reference Sharma SK, Kumpawat S, Goel A, Banga A, Ramakrishnan L et al (2007) Obesity, and not obstructive sleep apnea, is responsible for metabolic abnormalities in a cohort with sleep-disordered breathing. Sleep Med 8:12–17CrossRefPubMed Sharma SK, Kumpawat S, Goel A, Banga A, Ramakrishnan L et al (2007) Obesity, and not obstructive sleep apnea, is responsible for metabolic abnormalities in a cohort with sleep-disordered breathing. Sleep Med 8:12–17CrossRefPubMed
13.
go back to reference Nadeem R, Singh M, Nida M, Waheed I, Khan A et al (2014) Effect of obstructive sleep apnea hypopnea syndrome on lipid profile: a meta-regression analysis. J Clin Sleep Med 10:475–489PubMedPubMedCentral Nadeem R, Singh M, Nida M, Waheed I, Khan A et al (2014) Effect of obstructive sleep apnea hypopnea syndrome on lipid profile: a meta-regression analysis. J Clin Sleep Med 10:475–489PubMedPubMedCentral
14.
go back to reference Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF et al (1985) Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28:412–419CrossRefPubMed Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF et al (1985) Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28:412–419CrossRefPubMed
15.
go back to reference Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH et al (2005) Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute scientific statement. Circulation 112:2735–2752CrossRefPubMed Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH et al (2005) Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute scientific statement. Circulation 112:2735–2752CrossRefPubMed
16.
go back to reference Wang C, Hou X, Bao Y, Pan J, Zuo Y et al (2010) The metabolic syndrome increased risk of cardiovascular events in Chinese—a community based study. Int J Cardiol 139:159–165CrossRefPubMed Wang C, Hou X, Bao Y, Pan J, Zuo Y et al (2010) The metabolic syndrome increased risk of cardiovascular events in Chinese—a community based study. Int J Cardiol 139:159–165CrossRefPubMed
17.
go back to reference Peng LL, Li JR, Sun JJ, Li WY, Sun YM et al (2011) Reliability and validity of the simplified Chinese version of Epworth sleepiness scale. Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi 46:44–49PubMed Peng LL, Li JR, Sun JJ, Li WY, Sun YM et al (2011) Reliability and validity of the simplified Chinese version of Epworth sleepiness scale. Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi 46:44–49PubMed
18.
go back to reference Iber C, Ancoli-Israel S, Chesson AL, SF Q (2007) The AASM manual for the scoring of sleep and associated events: rules, terminology and technical specifications for the American Academy of Sleep Medicine. 1st ed. American Academy of Sleep Medicine, Westchester, IL Iber C, Ancoli-Israel S, Chesson AL, SF Q (2007) The AASM manual for the scoring of sleep and associated events: rules, terminology and technical specifications for the American Academy of Sleep Medicine. 1st ed. American Academy of Sleep Medicine, Westchester, IL
19.
go back to reference Togeiro SMCG, Ribeiro Filho FF, Zanella MT, Santos-Silva R, Taddei JA, Bittencourt LR, Tufik S (2013) Consequences of obstructive sleep apnea on metabolic profile: a population-based survey. Obesity (Silver Spring) 21:847–851CrossRef Togeiro SMCG, Ribeiro Filho FF, Zanella MT, Santos-Silva R, Taddei JA, Bittencourt LR, Tufik S (2013) Consequences of obstructive sleep apnea on metabolic profile: a population-based survey. Obesity (Silver Spring) 21:847–851CrossRef
20.
go back to reference Bhattacharjee R, Hakim F, Gozal D (2012) Sleep, sleep-disordered breathing and lipid homeostasis: translational evidence from murine models and children. Clin Lipidol 7:203–214CrossRefPubMedPubMedCentral Bhattacharjee R, Hakim F, Gozal D (2012) Sleep, sleep-disordered breathing and lipid homeostasis: translational evidence from murine models and children. Clin Lipidol 7:203–214CrossRefPubMedPubMedCentral
21.
go back to reference Can M, Acikgoz S, Mungan G, Bayraktaroglu T, Kocak E et al (2006) Serum cardiovascular risk factors in obstructive sleep apnea. Chest 129:233–237CrossRefPubMed Can M, Acikgoz S, Mungan G, Bayraktaroglu T, Kocak E et al (2006) Serum cardiovascular risk factors in obstructive sleep apnea. Chest 129:233–237CrossRefPubMed
22.
go back to reference Coughlin SR, Mawdsley L, Mugarza JA, Calverley PM, Wilding JP (2004) Obstructive sleep apnoea is independently associated with an increased prevalence of metabolic syndrome. Eur Heart J 25:735–741CrossRefPubMed Coughlin SR, Mawdsley L, Mugarza JA, Calverley PM, Wilding JP (2004) Obstructive sleep apnoea is independently associated with an increased prevalence of metabolic syndrome. Eur Heart J 25:735–741CrossRefPubMed
23.
go back to reference Tan KC, Chow WS, Lam JC, Lam B, Wong WK et al (2006) HDL dysfunction in obstructive sleep apnea. Atherosclerosis 184:377–382CrossRefPubMed Tan KC, Chow WS, Lam JC, Lam B, Wong WK et al (2006) HDL dysfunction in obstructive sleep apnea. Atherosclerosis 184:377–382CrossRefPubMed
24.
go back to reference Michailidis V, Steiropoulos P, Nena E, Papanas N, Maltezos E et al (2011) Continuous positive airway pressure treatment: effect on serum lipids in patients with obstructive sleep apnoea. Open Cardiovasc Med J 5:231–238CrossRefPubMedPubMedCentral Michailidis V, Steiropoulos P, Nena E, Papanas N, Maltezos E et al (2011) Continuous positive airway pressure treatment: effect on serum lipids in patients with obstructive sleep apnoea. Open Cardiovasc Med J 5:231–238CrossRefPubMedPubMedCentral
25.
go back to reference McArdle N, Hillman D, Beilin L, Watts G (2007) Metabolic risk factors for vascular disease in obstructive sleep apnea: a matched controlled study. Am J Respir Crit Care Med 175:190–195CrossRefPubMed McArdle N, Hillman D, Beilin L, Watts G (2007) Metabolic risk factors for vascular disease in obstructive sleep apnea: a matched controlled study. Am J Respir Crit Care Med 175:190–195CrossRefPubMed
26.
go back to reference Keenan BT, Maislin G, Sunwoo BY, Arnardottir ES, Jackson N et al (2014) Obstructive sleep apnoea treatment and fasting lipids: a comparative effectiveness study. Eur Respir J 44:405–414CrossRefPubMed Keenan BT, Maislin G, Sunwoo BY, Arnardottir ES, Jackson N et al (2014) Obstructive sleep apnoea treatment and fasting lipids: a comparative effectiveness study. Eur Respir J 44:405–414CrossRefPubMed
27.
go back to reference Kono M, Tatsumi K, Saibara T, Nakamura A, Tanabe N et al (2007) Obstructive sleep apnea syndrome is associated with some components of metabolic syndrome. Chest 131:1387–1392CrossRefPubMed Kono M, Tatsumi K, Saibara T, Nakamura A, Tanabe N et al (2007) Obstructive sleep apnea syndrome is associated with some components of metabolic syndrome. Chest 131:1387–1392CrossRefPubMed
28.
go back to reference Gruber A, Horwood F, Sithole J, Ali NJ, Idris I (2006) Obstructive sleep apnoea is independently associated with the metabolic syndrome but not insulin resistance state. Cardiovasc Diabetol 5:22CrossRefPubMedPubMedCentral Gruber A, Horwood F, Sithole J, Ali NJ, Idris I (2006) Obstructive sleep apnoea is independently associated with the metabolic syndrome but not insulin resistance state. Cardiovasc Diabetol 5:22CrossRefPubMedPubMedCentral
29.
go back to reference Schwartz CJ, Valente AJ, Sprague EA, Kelley JL, Nerem RM (1991) The pathogenesis of atherosclerosis: an overview. Clin Cardiol 14:I1–16CrossRefPubMed Schwartz CJ, Valente AJ, Sprague EA, Kelley JL, Nerem RM (1991) The pathogenesis of atherosclerosis: an overview. Clin Cardiol 14:I1–16CrossRefPubMed
30.
go back to reference Benn M, Nordestgaard BG, Grande P, Schnohr P, Tybjaerg-Hansen A (2010) PCSK9 R46L, low-density lipoprotein cholesterol levels, and risk of ischemic heart disease: 3 independent studies and meta-analyses. J Am Coll Cardiol 55:2833–2842CrossRefPubMed Benn M, Nordestgaard BG, Grande P, Schnohr P, Tybjaerg-Hansen A (2010) PCSK9 R46L, low-density lipoprotein cholesterol levels, and risk of ischemic heart disease: 3 independent studies and meta-analyses. J Am Coll Cardiol 55:2833–2842CrossRefPubMed
31.
go back to reference Baigent C, Blackwell L, Emberson J, Holland LE, Reith C et al (2010) Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials. Lancet 376:1670–1681CrossRefPubMed Baigent C, Blackwell L, Emberson J, Holland LE, Reith C et al (2010) Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials. Lancet 376:1670–1681CrossRefPubMed
Metadata
Title
Elevated low-density lipoprotein cholesterol is independently associated with obstructive sleep apnea: evidence from a large-scale cross-sectional study
Authors
Huajun Xu
Jian Guan
Hongliang Yi
Jianyin Zou
Lili Meng
Xulan Tang
Huaming Zhu
Dongzhen Yu
Huiqun Zhou
Kaiming Su
Yue Wang
Jian Wang
Shankai Yin
The Shanghai Sleep Health Study Research Group
Publication date
01-05-2016
Publisher
Springer Berlin Heidelberg
Published in
Sleep and Breathing / Issue 2/2016
Print ISSN: 1520-9512
Electronic ISSN: 1522-1709
DOI
https://doi.org/10.1007/s11325-015-1262-3

Other articles of this Issue 2/2016

Sleep and Breathing 2/2016 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.